Independent analysis of 10,605 ATTUNE® Knee procedures showed a cumulative revision rate of 1.3% at 4 years (or 98.7% implant survivorship), vs. a 1.9% cumulative revision rate (or 98.1% implant survivorship) for the overall class of total knee replacement.
The analysis was based on data from the National Joint Registry for England, Wales, Northern Ireland and the Isle of Man (NJR), and was presented at the 18th European Federation of the National Associations of Orthopaedics and Traumatology Congress (EFORT). Full analysis is available on ATTUNEevidence.com.
These results add to a growing body of clinical data published on the ATTUNE knee.
Source: DePuy Synthes
Independent analysis of 10,605 ATTUNE® Knee procedures showed a cumulative revision rate of 1.3% at 4 years (or 98.7% implant survivorship), vs. a 1.9% cumulative revision rate (or 98.1% implant survivorship) for the overall class of total knee replacement.
The analysis was based on data from the National Joint Registry...
Independent analysis of 10,605 ATTUNE® Knee procedures showed a cumulative revision rate of 1.3% at 4 years (or 98.7% implant survivorship), vs. a 1.9% cumulative revision rate (or 98.1% implant survivorship) for the overall class of total knee replacement.
The analysis was based on data from the National Joint Registry for England, Wales, Northern Ireland and the Isle of Man (NJR), and was presented at the 18th European Federation of the National Associations of Orthopaedics and Traumatology Congress (EFORT). Full analysis is available on ATTUNEevidence.com.
These results add to a growing body of clinical data published on the ATTUNE knee.
Source: DePuy Synthes
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.





